Cardiac myoblasts, integral to the cardiovascular system, play a vital role in the intricate dance of heart functionality. As specialized muscle cells, they contribute significantly to cardiac development during embryogenesis, intricately weaving the essential muscle fibers that form the foundation for effective blood pumping. Beyond their critical role in heart development, these cells are garnering attention in the realm of regenerative medicine. Researchers are actively exploring the potential of cardiac myoblasts to serve as a regenerative force, particularly in the repair of damaged heart tissue. The unique ability of cardiac myoblasts to mature into functional cardiac muscle cells positions them as a promising avenue for therapeutic interventions, with the potential to revolutionize approaches to treating cardiovascular diseases. Ongoing studies in this field hold the key to uncovering innovative strategies that could redefine the landscape of cardiac regenerative medicine.
Title : Revolutionizing CKD care: How finerenone transforms outcomes in heart and kidney health - Insights from fidelio-DKD
Robert J Chilton, University of Texas Health Science Center San Antonio, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options for pulmonary hypertension and right heart failure
Yong Xiao Wang, Albany Medical Center, United States
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : Empathy and precision: Revolutionizing communication between cardiologists and patients
Iris Panagiota Efthymiou, University of Greenwich, United Kingdom
Title : Post-cardiotomy ECMO (PC-ECMO)
Gustavo Lionel Knop, Mayo Clinic, United States
Title : The past, present and future of AI in cardiology
Narendra Kumar, HeartbeatsZ Academy, United Kingdom